Gilead Sciences (GILD) Announces FDA Approves Expanded Labeling for Epclusa

August 1, 2017 4:08 PM EDT Send to a Friend
Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved updated labeling for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login